Establishment and Characterization of NCC-MFS5-C1: A Novel Patient-Derived Cell Line of Myxofibrosarcoma

Establishment and Characterization of NCC-MFS5-C1: A Novel Patient-Derived Cell Line of Myxofibrosarcoma

Myxofibrosarcoma (MFS) is a highly aggressive malignancy with complex karyotypes and a postoperative recurrence tendency, owing to its strong invasiveness. Although systemic chemotherapy is considered in patients with unresectable MFS, the efficacy of conventional chemotherapy is hitherto unclear. R...

Full description

Bibliographic Details
Main Authors: Ryuto Tsuchiya, Yuki Yoshimatsu, Rei Noguchi, Yooksil Sin, Takuya Ono, Taro Akiyama, Jun Sugaya, Eisuke Kobayashi, Naoki Kojima, Akihiko Yoshida, Seiji Ohtori, Akira Kawai, Tadashi Kondo
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:Cells
Subjects:
sarcoma
myxofibrosarcoma
patient-derived cell line
drug screening
proteasome inhibitor
histone deacetylase inhibitor
Online Access:https://www.mdpi.com/2073-4409/11/2/207

Internet

https://www.mdpi.com/2073-4409/11/2/207

Similar Items